The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved $57 million to support 14 new comparative clinical effectiveness research studies, including studies on dementia, prostate cancer, and anxiety disorders.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors has approved $57 million in funding for 14 clinical effectiveness research studies. The funds will support studies for a range of conditions and problems that impose high burdens on patients, caregivers, and the healthcare system, said PCORI.
The funding includes $32 million for 3 large-scale pragmatic clinical studies focused on producing results that are broadly applicable to a wide variety of patients and care:
“Like all of our pragmatic clinical studies, these new awards will help answer significant questions regarding treatment and delivery of care that are important to patients and those who care for them,” Joe Selby, MD, MPH, executive director of PCORI, said in a statement. “These large studies feature the engagement of stakeholder groups on the research team and have been judged as having a high potential to change practice and improve patients’ outcomes.”
Additional studies that will receive funding include: